Page last updated: 2024-08-23

pirfenidone and plerixafor

pirfenidone has been researched along with plerixafor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Oupicky, D; Sun, M; Ullah, A; Wang, K; Wu, P	1

Other Studies

1 other study(ies) available for pirfenidone and plerixafor

Article	Year
CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation. International journal of nanomedicine, 2019, Volume: 14 Topics: Animals; Apoptosis; Benzylamines; Cell Line; Cell Line, Tumor; Cell Survival; Cyclams; Drug Delivery Systems; Endocytosis; Hepatic Stellate Cells; Heterocyclic Compounds; Humans; Liposomes; Liver Cirrhosis; Mice; p38 Mitogen-Activated Protein Kinases; Pyridones; Rats; Receptors, CXCR4; Signal Transduction; Tissue Distribution; Transforming Growth Factor beta	2019

Article

Year

CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation.

International journal of nanomedicine, 2019, Volume: 14

Topics: Animals; Apoptosis; Benzylamines; Cell Line; Cell Line, Tumor; Cell Survival; Cyclams; Drug Delivery Systems; Endocytosis; Hepatic Stellate Cells; Heterocyclic Compounds; Humans; Liposomes; Liver Cirrhosis; Mice; p38 Mitogen-Activated Protein Kinases; Pyridones; Rats; Receptors, CXCR4; Signal Transduction; Tissue Distribution; Transforming Growth Factor beta

2019